Antispasmodic effect of osthole and prangos ferulacea extract on rat uterus smooth muscle motility

Research in Pharmaceutical Sciences

Volumn 7, Issue 3, 2012, Pages 141-149

  Sadraei, H ^a   Shokoohinia, Y ^b   Sajjadi, S E ^a   Ghadirian, B ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ach; EFS; KCl; Osthole; Oxytocin; Prangos ferulacea

Indexed keywords

ACETYLCHOLINE; ATROPINE; OSTHOLE; OXYTOCIN; PLANT EXTRACT; POTASSIUM CHLORIDE; PRANGOS FERULACEA EXTRACT; SALBUTAMOL; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; FEMALE; IC 50; IN VITRO STUDY; MEDICINAL PLANT; MYOMETRIUM; NONHUMAN; PRANGOS FERULACEA; RAT; UTERUS CONTRACTILITY; UTERUS RELAXATION;

EID: 84873402035     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Evans WC. Trease and Evans' Pharmacognosy. 13th ed., Bailliere Tindall, London, 1989. p.205.
2. Zargari A. Medicinal Plants. Vol 2. Tehran: Tehran University Publications; 1988. p. 553.
3. Ulubelen A, Topcu G, Tan N, Olcal S, Johansson C, Ucer M, et al. Biological activities of a Turkish medicinal plant, Prangos platychlaena. J Ethnopharmacol. 1995;45:193-197.
4. Bouaoun D, Hilan C, Garabeth F, Sfeir R. Antimicrobial activity of the essential oil of the wildplant, Prangos asperula Boiss. Phytotherapia. 2007;5:129-134.
5. Razavi SM, Nazemiyeh H, Hajiboland R, Kumarasamy Y, Delazar A, Nahar L, et al. Coumarins from the aerial parts of Prangos uloptera (Apiaceae). Brazil J Pharmacognosy. 2008;18:1-5.
6. Eshbakova KA, Saidkhodzhaev AI, Baser KHC, Duman H, Vdovin AD, Abdullaev ND. Furocoumarins from Prangos ferulacea. Chem Nat Comp. 2006;42:102-103..
7. Tada Y, Shikishima Y, Takaishi Y, Shibata H, Higuti T, Honda G, et al. Coumarins and γ-pyrone derivatives from Prangos pabularia: antibacterial activity and inhibition of cytokine release. Phytochemistry. 2002;59:649-654.
8. Sefidkon F, Khajavi MS, Malackpour B. Analysis of the oil of Prangos ferulacea (L.) Lindl. J Essent Oil Res. 1998;10:81-82.
9. Baser KHC, Ozek T, Demirci B, Duman H. Composition of the essential oil of Prangos heyniae H. Duman et M. F. Watson, a new endemic from Turkey. Flavour Fragr J. 2000;15:47-49.
10. Sajjadi SE, Mehregan I. Chemical composition of of the essential oil of Prangos asperula Boiss. subsp. Haussknechtii (Boiss.) Herrnst. et Heyn fruits. Daru. 2003;11:79-81.
11. Sefidkon F, Najafpour Navaii M. Chemical composition of the oil of Prangos uloptera DC. J Essent Oil Res. 2001;13:84-85.
12. Masoudi S, Aghajani Z, Yari M, Rustaiyan A. Volatile constituents of Prangos latiloba Korov. J Essent Oil Res. 1999;11:767-768.
13. Ghahreman A. Flora of Iran. Research Institute of Forests and Rangelands Publication. Tehran, 1986. p. 845.
14. Coruh N, Sagdicoglu Celep AG, Ozgokce F. Antioxidant properties of Prangos ferulaceae (L.) Lindl., Chaerophyllum macropodum Boiss. and Heracleum persicum Desf. from Apiaceae family used as food in Eastern Anatolia and their inhibitory effects on glutathione-S-transferase. Food Chem. 2007;100:1237-1242.
15. Kazerooni T, Mousavizadeh K, Abdollahee A, Sarkarian M, Sattar A. Abortifacient effect of prangos ferulacia on pregnant rats.Contraception. 2006;73:554-556.
16. Sajjadi SE, Shokoohinia Y, Gholamzadeh S. Chemical Composition of the Essential Oil of the Root of Prangos ferulacea (L.) Lindl. Chemija. 2011;22:178-180.
17. Gholamzadeh S. Phytochemical investigation of the root of Prangos ferulacea (L.) Lindl. Pharm D Thesis. School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences. Isfahan, Iran, 2011.
18. Liu J, Zhang W, Zhou L, wang X, Lian Q, Antiinflammatory effect and mechanism of osthole in rats. Zhong Yao Cai. 2005;28:1002-1006.
19. Kuo PL, Hsu YL, Chang CH, Chang JK, Ostholemediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther. 2005;14:1290-1299.
20. Okamoto T, Kobayashi T, Yoshida S. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. Curr Med Chem Anticancer Agents. 2005;5:47-51.
21. Teng CM, Lin CH, Ko FN, Wu TS, Huang TF. The relaxant action of osthole isolated from Angelica pubescens in guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol. 1994;349:202-208.
22. Li L, Zhuang FE, Zhao GS, Zhoa DK. Effects of osthole on the isolated guinea-pig ileum and taeniae coli. Yao Xue Xue Bao. 1993;28:899-904.
23. Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM. Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. Eur J Pharmacol. 1992;219:29-34.
24. Hoult JR, Paya M, Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potrntial.1996;27:713-722.
25. Teng CM, Ko FN, Wang JP, Lin CN, Wu TS, Chen CC, Huang TF. Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J Pharm Pharmacol. 1999;43:667-669.
26. Li L, Zhuang F, Zhao G, Zhoa D. Effects of osthole on the contractive function of uterine smooth muscle. J Xi'an Med Univ (Chinese). 1994;15:164- 167.
27. SE Sajjadi, H Zeinvand, Y Shokoohinia. Isolation and identification of osthol from the fruits and essential oil composition of the leaves of Prangos asperula Boiss. Res Pharm Sci. 2009;4:19-23.
28. Committee for the update of the guide for the care and use of laboratory animals, National Research Council. Guide for the Care and use of Laboratory animals. Washington DC: The National Academies Press; 2010.
29. Houdeau E, Rossano B, Prud'homme MJ. Regional and muscle layer variations in cholinergic nerve control of the rat myometrium during the oestrous cycle. Auton Neurosci 2003;104:1-9.
30. Sadraei H, Ghannadi A, Takei-Bavani M. Effects of Zataria multiflora and Carum carvi essential oils and hydroalcoholic extract of Passiflora incarnatem, Berberis integerrima and Crocus sativus on rat isolated uterus contractions. Int J Aromather. 2003;13:121-127.
31. Parker KL, Schimmer BP. Pituitary hormones and their hypothalamic releasing hormones. In: Brunton LL, Lazo JS. Parker KL, editor. Goodman and Gilman's The Pharmacological Basis of Therapeutics.11th ed. New York, McGraw-Hill; 2006. p. 1489-1510.
32. Luciani S, Furlanut M. Interaction between dibucaine and K+ on smooth muscle. Pharmacol Res Commun. 1974;6:147-153.
33. Zoubina EV, Fan Q, Smith PG.Variations in uterine innervation during the estrous cycle in rat. J Comp Neurol. 1998;397:561-571.
34. Rang HP, Dale MM, Ritter JM, Moore P. Pharmacology. 6th ed., Churchill Livingstone: Edinburgh London; 2007. p. 144, 361, 367, 456.
35. Sato Y, Hotta H, Nakayama H, Suzuki H. Sympathetic and parasympathetic regulation of uterine blood flow and contraction in the rat. J Auton Nerv Syst 1996; 59:151-158.
36. Stjernquist M., Owman C.H. Cholinergic and adrenergic neural control of smooth muscle function in the non-pregnant rat uterine cervix. Acta Physiol Scand 1985;124:429-436.
37. Batra S. Influence of chronic estrogen treatment on the density of muscarinic cholinergic receptors and calcium channels in the rabbit uterus. J Endocrinol 1990;125:185-189.
38. Hollings worth M. Mechanical responses of rat isolated uterine horns to transmural stimulation. Br J Pharmacol. 1975;55:41-46.
39. Diamond J, Holmes TG. Effects of potassium chloride and smooth muscle relaxants on tension and cyclic nucleotide levels in rat myometrium. Can J Physiol Pharmcol. 1975;53:1099-1107.
40. Majerus PW, Tollefsen DM. Blood coagulation and anticoagulant, thrombolytic and antiplatelet drugs. In: Brunton LL, Lazo JS. Parker KL, editor. Goodman and Gilman's The Pharmacological Basis of Therapeutics.11th ed. New York, McGraw-Hill; 2006. p. 1467-1488.